InVitro Susceptibility Testing of Geotrichum capitatum :Comparison of the E-Test, Disk Diffusion, and Sensititre ColorimetricMethods with the NCCLS M27-A2 Broth Microdilution ReferenceMethod-Reference-Cited by-同舟云学术

InVitro Susceptibility Testing of Geotrichum capitatum :Comparison of the E-Test, Disk Diffusion, and Sensititre ColorimetricMethods with the NCCLS M27-A2 Broth Microdilution ReferenceMethod

Published:2003-12 Issue:12 Volume:47 Page:3985-3988
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Girmenia C.¹,Pizzarelli G.²,D'Antonio D.³,Cristini F.⁴,Martino P.¹

Affiliation:

1. Dipartimento di Biotecnologie Cellulari ed Ematologia, Università “La Sapienza,”

2. Pfizer Italia SpA, Rome

3. Servizio di Microbiologia Clinica del Dipartimento di Ematologia ed Oncologia, Ospedale Spirito Santo, Pescara

4. Clinica di Malattie Infettive, Dipartimento di Scienze Mediche e Morfologiche, Università di Udine, Udine, Italy

Abstract

ABSTRACT The in vitro activities of amphotericin B, flucytosine, fluconazole, itraconazole, and voriconazole against 23 isolates of Geotrichum capitatum were determined by the National Committee for Clinical Laboratory Standards (NCCLS) M27-A2 microdilution method and the Sensititre and agar diffusion methods. Amphotericin B and voriconazole appeared to be the more active drugs. Sensititre showed the highest rates of agreement with the NCCLS M27-A2 method.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.47.12.3985-3988.2003

Reference14 articles.

1. Anaissie, E., A. Gokaslan, R. Hachem, R. Rubin, G. Griffin, R. Robinson, J. Sobel, and G. Bodey. 1992. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin. Infect. Dis.15:781-787.

2. Precision and Accuracy of Fluconazole Susceptibility Testing by Broth Microdilution, Etest, and Disk Diffusion Methods

3. Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients

4. In Vitro Activity of the New Triazole Voriconazole (UK-109,496) against Opportunistic Filamentous and Dimorphic Fungi and Common and Emerging Yeast Pathogens

5. Girmenia, C., A. Micozzi, M. Venditti, G. Meloni, A. P. Iori, S. Bastianello, and P. Martino. 1991. Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur. J. Clin. Microbiol. Infect. Dis.10:752-756.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A RARE FUNGAL INFECTION: REPORT OF 17 SAPROCHAETE CAPITATA CASES;ACTA MEDICA MEDITERR;2022

2. Bloodstream infections caused by Magnusiomyces capitatus and Magnusiomyces clavatus: epidemiological, clinical and microbiological features of two emerging yeast species;Antimicrobial Agents and Chemotherapy;2021-12-20

3. Disseminated Saprochaete capitata fungal infection in a patient with acute myeloid leukemia;Clinical Case Reports;2021-02-26

4. Yeast Infections;Hematologic Malignancies;2020-10-22

5. Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.;Mediterranean Journal of Hematology and Infectious Diseases;2020-04-27